Consequently, lack of p53 activity may lead to an increase of FOXM1 protein expression and, consequently, of its targets, such as UBE2C, contributing to the loss of proper cell cycle control, a phenomenon highly present in ESCC [44]. This evidence concerns the gene TP53 and esophageal squamous cell carcinoma.